Pharma Leaders

FDA Approves Sarclisa for Certain Patients with Multiple Myeloma

2 months ago
by David Miller
946 Views

The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.

The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

Don`t Leave Yet!

Thank you!

[mwai_chat window="true" fullscreen="true"]